Q123015902 | (2952) Proposal to conserve the name Coccidioides posadasii against Posadasia esferiformis, Coccidium posadasi, Pseudococcidioides mazzae, Geotrichum louisianoideum, Glenospora meteuropea, Glenospora meta |
Q51614813 | A diagnostic predicament: activated sarcoidosis or pulmonary histoplasmosis. A case report. |
Q44015300 | Adherence of different Candida dubliniensis isolates in the presence of fluconazole |
Q38871747 | Allergic bronchopulmonary aspergillosis is associated with pet ownership in cystic fibrosis. |
Q52867528 | Arxula adeninivorans causing invasive pulmonary mycosis and fungaemia in cystic fibrosis. |
Q36318438 | Autochthonous and dormant Cryptococcus gattii infections in Europe |
Q41020744 | Cluster analysis of Scedosporium boydii infections in a single hospital |
Q44516468 | Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis |
Q57297487 | Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis |
Q44469244 | Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens |
Q36653764 | Cryptococcal meningoencephalitis relapse after an eight-year delay: an interplay of infection and immune reconstitution |
Q39472388 | Cryptococcosis due to Cryptococcus gattii in Germany from 2004-2013. |
Q92720697 | Disseminated Mycosis by Arthrocladium fulminans Jeopardizing a Patient with GATA2 Deficiency |
Q36020365 | Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin |
Q61717946 | Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin |
Q42581945 | Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) in fulminant blastomycosis in Germany |
Q43253198 | Fast, broad-range disinfection of bacteria, fungi, viruses and prions |
Q42208980 | First case of disseminated cryptococcosis in a Gorilla gorilla. |
Q48384491 | Gastrointestinal zygomycosis caused by Mucor indicus in a patient with acute traumatic brain injury |
Q36168992 | Identification and Characterization of VNI/VNII and Novel VNII/VNIV Hybrids and Impact of Hybridization on Virulence and Antifungal Susceptibility Within the C. neoformans/C. gattii Species Complex |
Q89068754 | Identification of 14-α-Lanosterol Demethylase (CYP51) in Scedosporium Species |
Q41165722 | Imported histoplasmosis |
Q30970755 | Imported systemic mycoses: are we prepared to diagnose these infections? |
Q37867831 | Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease--a diagnostic and therapeutic challenge. |
Q52620587 | Interlaboratory comparison of PCR-based identification of Candida and Aspergillus DNA in spiked blood samples. |
Q42787772 | Isolation of Cryptococcus adeliensis from clinical samples and the environment in Germany |
Q52804004 | Keratomycosis due to Tintelnotia destructans refractory to common therapy treated successfully with systemic and local terbinafine in combination with polyhexamethylene biguanide. |
Q52945465 | Lymphadenopathy in a pregnant woman from Brazil. |
Q83332740 | Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe |
Q41570453 | Molecular identification of fungal pathogens in nodular skin lesions of cats |
Q52876852 | Molecular typing of clinical Cryptococcus neoformans isolates collected in Germany from 2004 to 2010. |
Q44951465 | Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases |
Q36583160 | Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant population |
Q42242925 | Multiphasic and multifocal cryptococcal immune reconstitution inflammatory syndrome in an HIV-infected patient: interplay of infection and immunity |
Q35193147 | Name changes in medically important fungi and their implications for clinical practice. |
Q43128417 | Near-drowning and cerebral infections caused by fungi belonging to the Pseudallescheria / Scedosporium-complex |
Q35763934 | Pitfalls in Serological Diagnosis of Cryptococcus gattii Infections |
Q58034740 | Proposed nomenclature for Pseudallescheria, Scedosporium and related genera |
Q36274268 | Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors |
Q33368241 | Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning |
Q51149155 | Scedosporium and Lomentospora: an updated overview of underrated opportunists. |
Q37454251 | Successful prevention of scedosporiosis after lung transplantation in a cystic fibrosis patient by combined local and systemic triazole therapy |
Q79366058 | Successful topical therapy with voriconazole: pseudallescheriasis after injury |
Q46401149 | Successful treatment of relapsing disseminated coccidioidomycosis with cutaneous involvement with posaconazole |
Q35098705 | Susceptibility testing of fungi--current status and open questions. |
Q43064704 | Unusual presentation of Trichophyton verrucosum causing hydronephrosis and joint contractures |
Q79192911 | [Keratomycosis due to Cylindrocarpon lichenicola] |
Q74322302 | [Molecular biological identification of Cuninghamella spec] |
Q85258718 | [Progressive malaise and joint pain after travel to Costa Rica] |
Q37036556 | cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. |